Therapeutic Targeting of Both Dihydroorotate Dehydrogenase and Nucleoside Transport in MYCN-Amplified Neuroblastoma

0
35
Genetic and pharmacological inhibition of dihydroorotate dehydrogenase suppressed the proliferation and tumorigenicity of MYCN-amplified neuroblastoma cell lines.
[Cell Death & Disease]
Full Article